Royce & Associates’s Innovid Corp. CTV Stock Holding History

Royce & Associates’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,816,381	Closed	-$11.8M	–	879
2024 Q4	$11.8M	Sell	3,816,381 -560,340	-13%	-$1.32M	0.11%	278
2024 Q3	$7.88M	Buy	4,376,721 +223,940	+5%	+$407K	0.07%	371
2024 Q2	$7.68M	Buy	4,152,781 +249,098	+6%	+$534K	0.07%	386
2024 Q1	$9.72M	Buy	3,903,683 +104,022	+3%	+$180K	0.09%	335
2023 Q4	$5.7M	Buy	3,799,661 +553,561	+17%	+$705K	0.05%	468
2023 Q3	$4.16M	Buy	3,246,100 +463,703	+17%	+$543K	0.04%	515
2023 Q2	$3.03M	Buy	2,782,397 +2,293,127	+469%	+$2.38M	0.03%	599
2023 Q1	$690K	Buy	+489,270	New	+$894K	0.01%	812

Royce & Associates's CTV Position: Q1 2025 in Review

Royce & Associates sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 3,816,381 shares — an estimated $11.8M sold.

Royce & Associates first reported a position in CTV in Q1 2023 and held it in 8 quarters. The position peaked at $11.8M in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

Royce & Associates reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
Royce & Associates sold 3,816,381 Innovid Corp. shares in Q1 2025, an estimated $11.8M.
Royce & Associates first reported a position in Innovid Corp. in Q1 2023 and held it in 8 quarters.
Royce & Associates's Innovid Corp. position peaked at $11.8M in Q4 2024.
0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Royce & Associates's 13F filing for Q1 2025, filed 6 May 2025.